12,722
Total Claims
$2.0M
Drug Cost
1,125
Beneficiaries
$1,821
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+19%
Cost per patient vs peers
$1,821 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 10,593 claims · $210K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 542 | $506K |
| Rivaroxaban | 459 | $473K |
| Sacubitril/Valsartan | 290 | $333K |
| Evolocumab | 176 | $170K |
| Ticagrelor | 98 | $83K |
| Empagliflozin | 76 | $66K |
| Dapagliflozin Propanediol | 57 | $55K |
| Semaglutide | 40 | $47K |
| Icosapent Ethyl | 44 | $37K |
| Atorvastatin Calcium | 1,356 | $20K |
| Metoprolol Succinate | 847 | $16K |
| Potassium Chloride | 679 | $15K |
| Ranolazine | 106 | $14K |
| Ezetimibe | 449 | $14K |
| Evolocumab | 16 | $13K |
Prescribing Profile
Patient Profile
73
Avg Age
55%
Female
1.59
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About